Dr. Fang is a hospitalist and the Research Director of the University of California, San Francisco (UCSF) Division of Hospital Medicine. She also serves as the Medical Director of the UCSF Anticoagulation Clinic and directs the UCSF Academic Hospital Medicine Fellowship program. After graduating from the Honors Program in Medical Education at Northwestern University Medical School, she completed her internal medicine residency training at the Beth Israel Deaconess Medical Center in Boston. She then obtained additional research training through a General Medicine Fellowship at the Massachusetts General Hospital and obtained a Masters of Public Health at the Harvard School of Public Health.
As a cardiovascular epidemiologist and clinical outcomes researcher, Margaret’s research program focuses on how to optimize the use of anticoagulants to prevent stroke and treat venous thromboembolism. She is the Principal Investigator of the CVRN VTE and ALTERNATIVE Cohort Studies, cohorts of patients with venous thrombosis. She is also a core investigator in the CVRN ATRIA Study group, which investigates stroke and hemorrhage outcomes in patients with atrial fibrillation.